logo

For the Inventor, By the Inventor

CH

Antares Pharma Ipl Ag

Calculating rank
USPTO Granted Patents = 16

% Expired Patents = 62.5



Forward Citations = 435

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Arnaud Grenier (9 out of 14 patents)

silverMedal Dario Norberto R Carrara (6 out of 6 patents)

bronzeMedal Leah M Lehman (6 out of 6 patents)

4.  Stephen M Simes (6 out of 6 patents)

5.  Celine Besse (5 out of 5 patents)

6.  Dario Carrara (2 out of 4 patents)

7.  Gabriel Porto (2 out of 2 patents)

8.  Jorge Rodriguez (2 out of 2 patents)

9.  R Dario Norberto Carrara (2 out of 2 patents)

10.  Regine Sitruk-Ware (1 out of 6 patents)

11.  Dario Norberto Ramon Carrara (1 out of 1 patent)

12.  Etienne Pionnier (1 out of 1 patent)

13.  Isabelle Rault (1 out of 2 patents)

14.  Dario Norberto Carrara (0 patent)

15.  Jorge c/o Antares Pharma Ag Rodriguez (0 patent)


16 patents:

1. 9682087 - Nestorone®/estradiol transdermal gel (2017-06-20),
2. 8980309 - Transdermal testosterone formulation for minimizing skin residues (2015-03-17),
3. 8980290 - Transdermal compositions for anticholinergic agents (2015-03-17),
4. 8652491 - Transdermal compositions for anticholinergic agents (2014-02-18),
5. 8647665 - Methods of treating hot flashes with formulations for transdermal or transmucosal application (2014-02-11),
6. 8338400 - Methods and apparatus for transdermal or transmucosal application of testosterone (2012-12-25),
7. 8268346 - Methods of treating hot flashes with formulations for transdermal or transmucosal application (2012-09-18),
8. 8067399 - Method and apparatus for transdermal or transmucosal application of testosterone (2011-11-29),
9. 7470433 - Formulations for transdermal or transmucosal application (2008-12-30),
10. 7425340 - Permeation enhancing compositions for anticholinergic agents (2008-09-16),
11. 7404965 - Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels (2008-07-29),
12. 7387788 - Pharmaceutical compositions of nicotine and methods of use thereof (2008-06-17),
13. 7335379 - Transdermal pharmaceutical formulation for minimizing skin residues (2008-02-26),
14. 7214381 - Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels (2007-05-08),
15. 7198801 - Formulations for transdermal or transmucosal application (2007-04-03),
Company Overview
Antares Pharma Ipl Ag is a Swiss-based company specializing in the development and manufacturing of innovative drug delivery systems. The organization focuses on enhancing the administration of medications through advanced technologies, particularly in the areas of injectable and transdermal delivery. With a commitment to improving patient outcomes, Antares Pharma leverages its expertise in formulation and device design to create solutions that address unmet medical needs across various therapeutic areas.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

16 Patents

#37 in

#764 in Switzerland

#37,887 in the World

CH
CH

Antares Pharma Ipl Ag

Forward Citations = 435

13 inventors:

goldMedal Arnaud Grenier (9 out of 14 patents)

silverMedal Dario Norberto R Carrara (6 out of 6 patents)

bronzeMedal Leah M Lehman (6 out of 6 patents)

4.  Stephen M Simes (6 out of 6 patents)

5.  Celine Besse (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Antares Pharma Ipl Ag. Retrieved from https://idiyas.com/company/antares-pharma-ipl-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…